Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Listening...

Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. Home/
    2. News/
    3. Innovation/
    4. Innovation-opedia: What is a mosaic vaccine?
    Graphic featuring a syringe to illustrate an HIV vaccine trial
    Innovation

    Innovation-opedia: What is a mosaic vaccine?

    As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

    Written by Johnson & Johnson
     | July 22, 2019
    July 22, 2019
    Illustrated handwritten definition of a mosaic HIV vaccine
    Illustration of a microscope with information about Janssen Vaccines & Prevention B.V. investigational HIV-1 vaccine regimen
    Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_above
    Illustration of the # 4 explaining how many injections would be administered for Janssen’s investigational HIV-1 vaccine.
    Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_below
    Illustration showing location of the IAS Conference on HIV Science with details about Janssen’s new Mosaico clinical trial.
    Illustrated quote by Janssen’s Maria Grazia Pau talking about the goal of creating a global HIV vaccine.

    We’re committed to helping lead the fight against HIV/AIDS

    Read about the many ways Johnson & Johnson is working to #makeHIVhistory.
    Learn more
    CTA-Red ribbon HIV

    HIV vaccine J&J Innovative Medicine Johnson & Johnson

    More from Johnson & Johnson

    Caring & giving
    March 17, 2026

    Meet two Johnson & Johnson nurse educators dedicated to teaching cancer care providers

    Jennifer Huff and Jacqui Mellott are two of Johnson & Johnson’s oncology clinical educators—a team of 56 nurses who visit hospitals and infusion centers to help providers understand and stay up to date with treatments.
    Read more
    Innovation
    March 13, 2026

    5 things we now know about plaque psoriasis

    Plaque psoriasis is the most prevalent form of psoriasis, affecting millions worldwide. Johnson & Johnson is focused on developing novel therapies for chronic dermatologic diseases to address the unmet need that still exists.
    Read more
    Innovation
    March 4, 2026

    Getting in front of cancer

    Every year, roughly 2 million people in the U.S. are newly diagnosed with cancer. But new scientific breakthroughs—including ones made at Johnson & Johnson—have dramatically changed the prognosis of many of these patients.
    Read more